April 9th 2020
Centivo has launched a new health plan solution, aimed at lowering costs for employees; trial results show dead bacteria may be effective in treating IBS; continuous glucose monitoring systems are now being used in hospitalized patients with diabetes and coronavirus disease 2019 (COVID-19).
USPSTF Evidence Review Could Lead to Revised Screening Guidelines
April 15th 2015Recent emphasis of identifying those with prediabetes and intervening to halt its progression is aimed at reducing the financial impact of diabetes in the United States, which was estimated in 2012 at $245 billion.
Read More
As NYC's Big Soda Ban Awaits de Blasio, Science Firmly on the Side of Smaller Portions
December 23rd 2013This month's edition of Evidence-Based Diabetes Management, a news source of The American Journal of Managed Care, examines the science behind Mayor Michael Bloomberg's pursuit of soda portion limits, as well as alternatives for curtailing consumption to fight obesity. Soon after Mayor-elect de Blasio takes office, he must decide how to achieve Bloomberg's goal, including whether to continue litigation before the New York State Court of Appeals.
Read More
With MiniMed 530G, Medtronic Seeks New CMS Code
October 1st 2013With the unveiling of the first FDA-approved system with the name "artificial pancreas," Medtronic will seek a new CMS code that would cover both the insulin pump and the continuous glucose monitoring parts of the process, according to the company.
Read More
With speculation about an artificial pancreas rising, the September edition of Evidenced-Based Diabetes Management looked at the three systems that were being considered by the FDA including the threshold suspend technology Medtronic announced Friday and asked the next questions: Assuming the technology is approved, will insurers pay for it? How will this potentially life-altering advance make its way into the hands of the persons with diabetes who need it most?
Read More